Suvoda
Private Company
Total funding raised: $35M
Overview
Suvoda is a private, revenue-generating digital health company founded in 2013 and headquartered in Barcelona, Spain. It offers a unified, patented platform that integrates eight core products—including IRT, eCOA, eConsent, and patient financial solutions—to simplify operational challenges in clinical trials, particularly in high-stakes therapeutic areas like oncology, rare disease, and CNS. Backed by expert client services, Suvoda supports over 2,000 trials across 95+ countries, positioning itself as a trusted operational partner for the life sciences industry.
Technology Platform
A unified, real-time software platform for clinical trial execution. It integrates eight modular products: IRT (Interactive Response Technology), eCOA (electronic Clinical Outcome Assessments), eConsent, Greenphire Patient Payments, Greenphire Travel Scheduling, a Patient App, Site Payments, and Budgeting & Benchmarking. The platform is designed to synchronize data and activity across sponsors, CROs, sites, and patients, streamlining complex trial workflows.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Suvoda competes in the fragmented clinical trial technology market against large enterprise vendors like Veeva Systems and Medidata (a Dassault Systèmes company), as well as numerous best-of-breed point solution providers in IRT, eCOA, and patient convenience. Its key differentiator is the depth of integration across its eight modules, its focus on critical trial moments, and its specialized expertise in complex disease trials.